title: [Lymphatic tuberculosis with an atypical presentation in a patient with myelodysplastic syndrome: an unusual association].
authors.forename: M
authors.initials: M
authors.lastname: Arenas
authors.forename: A
authors.initials: A
authors.lastname: Tovar
authors.forename: V
authors.initials: V
authors.lastname: Martínez
authors.forename: J V
authors.initials: JV
authors.lastname: Calduch
authors.forename: M
authors.initials: M
authors.lastname: del Mar Segarra
authors.forename: B
authors.initials: B
authors.lastname: Mata
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000753:Anemia, Refractory / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D000756:Anemia, Sideroblastic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007538:Isoniazid / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use; D014388:Tuberculosis, Lymph Node / Q000150:complications* / Q000188:drug therapy; D014803:Vitamin B Complex / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D014803:Vitamin B Complex; D004977:Ethambutol; D005492:Folic Acid; D013974:Thyroxine; D007538:Isoniazid; D012293:Rifampin